is an antibody drug conjugate that is approved for use in acute myeloid leukemia, and being studied for use in other indications.
| SparkCures ID | 560 |
|---|---|
| Brand Name | Mylotarg®® |
| Generic Name | Gemtuzumab Ozogamicin |
| Treatment Classifications | |
| Treatment Targets |
There are no resources, links or videos to display for this treatment.